文献速递头颈部肿瘤放疗

头颈癌患者脑干或前庭器官受照剂量与恶心呕吐毒性的相关性观察

Correlation between delivered radiation doses to the brainstem or vestibular organ and nausea & vomiting toxicity in patients with head and neck cancers - an observational clinical trial.
PubMed 文献 · Radiat Oncol · 2017-07-04

本研究在26例接受IMRT的头颈部肿瘤患者中评估脑干亚区及前庭系统受照剂量与恶心呕吐(NV)的关系,共记录98次毒性评分。65.4%的患者治疗期间至少出现一次NV,口咽部治疗、女性及年轻患者NV更常见,但ROC分析等未显示剂量与毒性显著相关。建议在无确证数据前依据已发表脑干耐受量,不牺牲靶区覆盖。

要点

  • 26例头颈癌IMRT患者中65.4%治疗期间至少出现一次恶心呕吐。
  • 口咽部治疗、女性及年轻患者恶心呕吐更频繁。
  • 脑干亚区及前庭系统剂量与恶心呕吐无显著相关性。

核心结论

  • 本分析未发现脑干或前庭系统受照剂量与恶心呕吐发生存在显著相关性。
  • 在获得确证数据前,建议依据已发表的脑干耐受量数据,不牺牲剂量覆盖。

研究设计与样本

  • 观察性临床试验,纳入26例接受根治性IMRT的头颈部肿瘤患者,记录98次毒性评分并与剂量分布相关分析。
  • 患者接受常规分割或同步 integrated boost IMRT,勾画脑干亚区及前庭系统,毒性按CTCAE 4.0评级。

主要发现

  • 65.4%的患者治疗期间至少出现一次恶心呕吐。
  • 口咽部治疗较下咽部治疗、女性及年轻患者恶心呕吐更频繁。
  • ROC分析及组内/组间分析未显示脑干亚区或前庭系统剂量与毒性显著相关。

临床怎么用

  • 头颈癌IMRT计划设计时不应为降低恶心呕吐而主动降低脑干或前庭系统剂量约束,应优先保证靶区覆盖。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Today intensity modulated radiation therapy (IMRT) can be considered the standard of care in patients with head and neck tumors. IMRT treatment plans are proven to reduce acute treatment related side effects by optimal sparing of organs at risk (OAR). At the same time, areas that were out of the former 3D fields now receive low radiation doses. Amongst those areas the brainstem (BS) and the vestibular system (VS) are known to be physiologically connected to nausea and vomiting (NV). In our study we tried to find out, if doses to these areas are linked to NV. MATERIAL & METHODS: NV were assessed at different time points during treatment in 26 patients leading to 98 documented toxicity scores that were later correlated to dose deposition in the described areas. Patients were either treated with normo-fractionated or simultaneously integrated boost IMRT plans in a curative approach. Subareas of the BS as well as the VS were delineated. Toxicity was rated based on the common toxicity criteria (CTCAE Version 4.0). Other factors such as age, gender, chemotherapy, location of the tumor, irradiated volume and unilateral dose to the VS were taken into account and analyzed also. RESULTS: The majority (65.4%) of our patients experienced an episode of NV at least once during treatment. NV was more frequent when treating the oropharyngeal region compared to the hypopharyngeal region, as well as when patients were female and/ or of a younger age. Nevertheless, upon statistical analysis (ROC analysis, 'within/ between analysis') no significant association between delivered doses to subareas and toxicity could be demonstrated. CONCLUSION: In our analysis, no significant correlation between radiation dose to the BS or the VS and the occurrence of NV could be found. Therefore, until conclusive data are available, we recommend to rely on the published data regarding OAR tolerance within the BS and not to compromise on dose coverage.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Schiller K, Specht HM, Haller B, et al. Correlation between delivered radiation doses to the brainstem or vestibular organ and nausea & vomiting toxicity in patients with head and neck cancers - an observational clinical trial. Radiat Oncol. 2017. PMID: 28676068. doi:10.1186/s13014-017-0846-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。